PF-08032562

· Pfizer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for PF-08032562, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors [Phase 1]

See pricing